Developer docs
API playgroundTry for free, no card

Search company profiles

Eyecelerator

Full company profile

uuid0006wk7

Namestring
Eyecelerator
Legal namestring
Eyecelerator
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Eyecelerator is a private, conference-and-content platform focused exclusively on ophthalmology innovation, structured as a program of the American Academy of Ophthalmology (AAO). The company organizes next-generation business conferences co-located with AAO and ARVO annual meetings, featuring key opinion leader (KOL)-driven programs on translational research, clinical development, manufacturing, regulatory strategy, and market access. Presenting companies—curated by an Eyecelerator Program Committee of seasoned ophthalmic professionals—pitch from stage to an audience of investors, physicians, and industry leaders, with 40 companies presenting at the ARVO 2026 event across three simultaneous breakout rooms and presentation video remaining on the Eyecelerator website for one year. The Eye to Market web series, produced with Unither Pharmaceuticals and Ora, extends the platform into on-demand digital content distributed via YouTube and partner channels.

The core technology is therefore event curation and content distribution rather than software: it consists of a Program Committee vetting pipeline, a tiered sponsorship stack (Palladium at $115,000 full-year down to Bronze at $15,000 full-year), a presenting-company application and selection workflow ($5,000 per meeting, waived for sponsors), and a tiered attendee registration model ($750 general / $425 AAO–ARVO members / $75 in training). Commercial reach currently sits within the United States, anchored by flagship sponsor relationships with Alcon, Astellas, AbbVie, Ocular Therapeutix, Regeneron, Bausch & Lomb, Johnson & Johnson Vision, and Adverum/Eli Lilly, alongside co-founder Gil Kliman, MD's affiliation with $2B AUM InterWest Partners as a structural channel into ophthalmology venture capital.

Eyecelerator's customer base spans four primary segments: ophthalmology entrepreneurs seeking capital and visibility, ophthalmology-focused investors seeking curated deal flow, physician KOLs serving on program committees and moderating sessions, and pharma/medtech companies purchasing sponsorship for brand positioning and early access to emerging technologies. The company is governed by California law, headquartered at 655 Beach Street in San Francisco, and operates as a private entity without disclosed funding rounds, revenue figures, or ownership percentages, with AAO functioning as the parent/partner organization and Stephen D. McLeod, MD (AAO CEO) on the board.

Short descriptiontext

Eyecelerator is a private ophthalmology innovation platform, operated as a program of the American Academy of Ophthalmology, that runs curated business conferences at AAO and ARVO meetings and the Eye to Market web series, connecting ophthalmology entrepreneurs, investors, physicians, and pharma/medtech sponsors.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSan Francisco, United States
HQ citystring
San Francisco
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
ophthalmology innovation events, medical conference services, healthcare venture networking, eye care investment platform, KOL ophthalmology meetings
Industry4 codes
PRIMARYMPAGAGAB
Professional & Association Conferences
SECONDARYMPAGAGAM
Conferences & Conventions Operations Services (Registration, AV, Logistics)
SECONDARYTHAHABAH
Healthcare, Medical Devices & Pharma Shows Organizers
SECONDARYMPAGAGAJ
Training, Workshops & Certification Events
NAICS code2 codes
  • Convention and Trade Show Organizers561920
  • Convention and Trade Show Organizers56192
SIC code1 code
  • Services-Membership Organizations8600
Product category
Ophthalmology Innovation Conferences
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Sponsorship Revenue
TypeSubscription Recurring
Description

Eyecelerator generates revenue through tiered sponsorship packages (Palladium, Platinum, Gold, Bronze) with pricing ranging from $10,000 for one-meeting Bronze sponsorship to $115,000 for full-year Palladium sponsorship. Sponsors receive benefits including passes, logo placement, networking opportunities, and speaking slots.

eyecelerator.com
2Presenting Company Fees
TypeOne Time License
Description

Companies selected to present from stage pay a $5,000 fee per meeting. Benefits include networking location, presentation featured on website, and 2 free passes. Sponsors who apply and are selected have this fee waived.

eyecelerator.com
3Conference Registration Fees
TypeOne Time License
Description

Revenue from attendee registration fees at live conferences. Eyecelerator @ Park City charged $750 for general attendees, $425 for ARVO/AAO members, and $75 for those in training.

eyecelerator.com
4Eye to Market Web Series
TypeAdvertising
Description

Content series developed in collaboration with Unither Pharmaceuticals and Ora, distributed via Eyecelerator YouTube channel and shared across partner channels, providing brand exposure and thought leadership opportunities.

eyecelerator.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Operations, Personnel, Marketing or Sales, Technology or R&D, Others
Pricing details7 tiers
1General Attendee Registration
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

$750 for general attendees at Eyecelerator @ Park City conference

eyecelerator.com
2Member Registration
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

$425 for ARVO/AAO Members; $75 for those In Training

eyecelerator.com
3Palladium Sponsorship
ModelSubscriptionBilling cadenceAnnual
Notes

Full year: $115,000 | One meeting: $60,000. Benefits include 2 Executive Committee meeting invitations, private networking session, hospitality suite, 30 free passes, video distribution, logo display, and sponsor employee discount.

eyecelerator.com
4Platinum Sponsorship
ModelSubscriptionBilling cadenceAnnual
Notes

Full year: $60,000 | One meeting: $32,500. Includes agenda feedback opportunity, logo display, and 20 free passes per meeting.

eyecelerator.com
5Gold Sponsorship
ModelSubscriptionBilling cadenceAnnual
Notes

Full year: $30,000 | One meeting: $17,500. Includes program interaction, logo display, and 10 free passes per meeting.

eyecelerator.com
6Bronze Sponsorship
ModelSubscriptionBilling cadenceAnnual
Notes

Full year: $15,000 | One meeting: $10,000. Includes 7 free passes per meeting.

eyecelerator.com
7Presenting Company Fee
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

$5,000 per meeting. Waived if sponsor applies and is selected. Includes stage presentation, designated networking location, website featuring, and 2 free passes.

eyecelerator.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Eyecelerator organizes and hosts next-generation business conferences at major ophthalmology industry meetings, including AAO (American Academy of Ophthalmology) and ARVO (Association for Research in Vision and Ophthalmology), featuring KOL-driven programs, presenting company showcases, and curated networking. It complements live events with the "Eye to Market" web series that explores ophthalmic innovation from research to patient adoption. The platform connects ophthalmology entrepreneurs, investors, physicians, and industry leaders through sponsorship, presenting company slots, and attendee registration.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 40 companies present at ARVO 2026 across three simultaneous breakout rooms
+1 more record
Product overview1 text field

Eyecelerator is a conference and event company focused on ophthalmology innovation. The core offering consists of Eyecelerator Conferences held at major ophthalmology meetings (AAO, ARVO, and standalone events), where the company organizes KOL-driven programs featuring industry advancements, investment trends, and innovative products. Supporting offerings include the 'Eye to Market' web series (produced in partnership with Ora and Unither Pharmaceuticals) and the Presenting Company Showcase program where selected companies present novel clinical treatments and emerging technologies.

Product and service2 records
1Eyecelerator Conferences
CategoryInnovation Conferences
Description

Full-day, KOL-driven business conferences held at AAO and ARVO annual meetings (e.g., Eyecelerator @ AAO 2026 on Oct. 8 in New Orleans, ARVO 2026, Eyecelerator @ Park City). Each event features presenting company showcases across three simultaneous breakout rooms, expert panels on industry advancements and investment trends, and networking sessions. Designed for ophthalmology entrepreneurs, investors, physicians, and industry leaders.

2Eye to Market Web Series
CategoryDigital Content / Web Series
Description

A web video series developed with Unither Pharmaceuticals and Ora that explores how ophthalmic innovations move from concept to patient care, featuring expert interviews on translational research, clinical development, manufacturing, regulatory strategy, and market access. Episodes are published on the Eyecelerator YouTube channel and shared across partner channels, targeting innovators, clinicians, investors, manufacturers, and industry leaders globally.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
1American Academy of Ophthalmology
Strategic tierCoreTypeStrategic or Co-development Partner
Description

The American Academy of Ophthalmology is Eyecelerator's program partner. AAO is the world's largest association of eye physicians and surgeons with 32,000 members. Eyecelerator is brought to you by AAO, which protects sight and empowers lives by setting standards for ophthalmic education and advocating for patients and the public.

eyecelerator.com
Strategic tierFlagshipTypeGTM or Marketing Partner
Description

Eyecelerator announced collaboration with Unither Pharmaceuticals and Ora to launch 'Eye to Market,' a new web series exploring how ophthalmic innovations move from scientific development to real-world patient adoption. The series features expert interviews covering topics including translational research, clinical development, manufacturing, regulatory strategy, and market access.

Strategic tierFlagshipTypeGTM or Marketing Partner
Description

Eyecelerator collaboration with Ora, Inc. and Unither Pharmaceuticals on 'Eye to Market' web series. Ora is a major ophthalmology contract research organization. Episodes published on Eyecelerator YouTube channel and shared across partner channels targeting innovators, clinicians, investors, manufacturers, and industry leaders.

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Predecessor and closest direct competitor to Eyecelerator — a conference series convening ophthalmology entrepreneurs, clinicians, and investors to showcase emerging companies and technologies.

2Biotech Showcase
TypeDirect peer
Description

Investor and partnering conference held alongside the J.P. Morgan Healthcare Conference where emerging biotech and medtech companies present to investors — same presenting-company + sponsor + investor model as Eyecelerator.

3RESI Conference (Redefining Early Stage Investments)
TypeDirect peer
Description

Life-sciences early-stage investor conference series featuring presenting companies and panel-driven programming for entrepreneurs and investors — directly comparable event format and target audience.

4BIO International Convention
TypeBroad incumbent
Description

Largest global biotech partnering event operated by the Biotechnology Innovation Organization; competes for the same enterprise sponsors and presenting-company dollars across all therapeutic areas including ophthalmology.

TypeBroad incumbent
Description

The flagship annual healthcare investment conference that draws presenting biotechs, medtechs, and investors — a major competitor for sponsor mindshare and presenting-company visibility in healthcare.

6AAO Annual Meeting (American Academy of Ophthalmology)
TypeBroad incumbent
Description

The parent organization's own flagship clinical meeting — provides the distribution and audience pipeline that Eyecelerator leverages, and is the platform's largest adjacent clinical event.

7ARVO Annual Meeting (Association for Research in Vision and Ophthalmology)
TypeBroad incumbent
Description

Premier vision-research conference where Eyecelerator co-locates its innovation programming — competing adjacent event with overlapping scientific and KOL audiences.

TypeBroad incumbent
Description

Major ophthalmic surgeon society meeting with its own industry programming, exhibits, and innovation sessions that compete for sponsor and presenter attention in the ophthalmology space.

TypeEmerging player
Description

Healthcare investor conference series with themed tracks (including medical devices) and presenting-company showcases — comparable emerging format targeting a similar investor/entrepreneur audience.

TypeRegional player
Description

Europe's largest biotech partnering conference — comparable presenting-company and sponsor model but focused on European life sciences, complementing Eyecelerator's US-centric footprint.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Eyecelerator

Ophthalmology Innovation Conferenceseyecelerator.com

Eyecelerator is a private ophthalmology innovation platform, operated as a program of the American Academy of Ophthalmology, that runs curated business conferences at AAO and ARVO meetings and the Eye to Market web series, connecting ophthalmology entrepreneurs, investors, physicians, and pharma/medtech sponsors.

What Eyecelerator does

Eyecelerator is a private, conference-and-content platform focused exclusively on ophthalmology innovation, structured as a program of the American Academy of Ophthalmology (AAO). The company organizes next-generation business conferences co-located with AAO and ARVO annual meetings, featuring key opinion leader (KOL)-driven programs on translational research, clinical development, manufacturing, regulatory strategy, and market access. Presenting companies—curated by an Eyecelerator Program Committee of seasoned ophthalmic professionals—pitch from stage to an audience of investors, physicians, and industry leaders, with 40 companies presenting at the ARVO 2026 event across three simultaneous breakout rooms and presentation video remaining on the Eyecelerator website for one year. The Eye to Market web series, produced with Unither Pharmaceuticals and Ora, extends the platform into on-demand digital content distributed via YouTube and partner channels.

The core technology is therefore event curation and content distribution rather than software: it consists of a Program Committee vetting pipeline, a tiered sponsorship stack (Palladium at $115,000 full-year down to Bronze at $15,000 full-year), a presenting-company application and selection workflow ($5,000 per meeting, waived for sponsors), and a tiered attendee registration model ($750 general / $425 AAO–ARVO members / $75 in training). Commercial reach currently sits within the United States, anchored by flagship sponsor relationships with Alcon, Astellas, AbbVie, Ocular Therapeutix, Regeneron, Bausch & Lomb, Johnson & Johnson Vision, and Adverum/Eli Lilly, alongside co-founder Gil Kliman, MD's affiliation with $2B AUM InterWest Partners as a structural channel into ophthalmology venture capital.

Eyecelerator's customer base spans four primary segments: ophthalmology entrepreneurs seeking capital and visibility, ophthalmology-focused investors seeking curated deal flow, physician KOLs serving on program committees and moderating sessions, and pharma/medtech companies purchasing sponsorship for brand positioning and early access to emerging technologies. The company is governed by California law, headquartered at 655 Beach Street in San Francisco, and operates as a private entity without disclosed funding rounds, revenue figures, or ownership percentages, with AAO functioning as the parent/partner organization and Stephen D. McLeod, MD (AAO CEO) on the board.

Eyecelerator firmographics

Firmographics
Name
Eyecelerator
Legal name
Eyecelerator
Website
https://eyecelerator.com
Company type
Private
Operating status
Operating
Headcount range
1–10 employees
Short description
Eyecelerator is a private ophthalmology innovation platform, operated as a program of the American Academy of Ophthalmology, that runs curated business conferences at AAO and ARVO meetings and the Eye to Market web series, connecting ophthalmology entrepreneurs, investors, physicians, and pharma/medtech sponsors.
Ownership category
akta.pro rank

Eyecelerator industry classification

Industry
Product category
Ophthalmology Innovation Conferences
NAICS
Convention and Trade Show Organizers (561920), Convention and Trade Show Organizers (56192)
SIC
Services-Membership Organizations (8600)
akta.pro industry
PRIMARYMPAGAGAB
Professional & Association Conferences
SECONDARYMPAGAGAM
Conferences & Conventions Operations Services (Registration, AV, Logistics)
SECONDARYTHAHABAH
Healthcare, Medical Devices & Pharma Shows Organizers
SECONDARYMPAGAGAJ
Training, Workshops & Certification Events

Keywords

  • Ophthalmology innovation events
  • Medical conference services
  • Healthcare venture networking
  • Eye care investment platform
  • KOL ophthalmology meetings

Where Eyecelerator is headquartered

Location

Headquarters

HQ city
San Francisco
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Eyecelerator business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Operations, Personnel, Marketing or Sales, Technology or R&D, Others

Revenue model

  1. Sponsorship Revenue: Eyecelerator generates revenue through tiered sponsorship packages (Palladium, Platinum, Gold, Bronze) with pricing ranging from $10,000 for one-meeting Bronze sponsorship to $115,000 for full-year Palladium sponsorship. Sponsors receive benefits including passes, logo placement, networking opportunities, and speaking slots.
  2. Presenting Company Fees: Companies selected to present from stage pay a $5,000 fee per meeting. Benefits include networking location, presentation featured on website, and 2 free passes. Sponsors who apply and are selected have this fee waived.
  3. Conference Registration Fees: Revenue from attendee registration fees at live conferences. Eyecelerator @ Park City charged $750 for general attendees, $425 for ARVO/AAO members, and $75 for those in training.
  4. Eye to Market Web Series: Content series developed in collaboration with Unither Pharmaceuticals and Ora, distributed via Eyecelerator YouTube channel and shared across partner channels, providing brand exposure and thought leadership opportunities.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goGeneral Attendee Registration
One time/ perpetual licensePay-as-you-goMember Registration
SubscriptionAnnualPalladium Sponsorship
SubscriptionAnnualPlatinum Sponsorship
SubscriptionAnnualGold Sponsorship
SubscriptionAnnualBronze Sponsorship
One time/ perpetual licensePay-as-you-goPresenting Company Fee

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Eyecelerator product offering

Product offering

Core offering

Eyecelerator organizes and hosts next-generation business conferences at major ophthalmology industry meetings, including AAO (American Academy of Ophthalmology) and ARVO (Association for Research in Vision and Ophthalmology), featuring KOL-driven programs, presenting company showcases, and curated networking. It complements live events with the "Eye to Market" web series that explores ophthalmic innovation from research to patient adoption. The platform connects ophthalmology entrepreneurs, investors, physicians, and industry leaders through sponsorship, presenting company slots, and attendee registration.

Product overview

Eyecelerator is a conference and event company focused on ophthalmology innovation. The core offering consists of Eyecelerator Conferences held at major ophthalmology meetings (AAO, ARVO, and standalone events), where the company organizes KOL-driven programs featuring industry advancements, investment trends, and innovative products. Supporting offerings include the 'Eye to Market' web series (produced in partnership with Ora and Unither Pharmaceuticals) and the Presenting Company Showcase program where selected companies present novel clinical treatments and emerging technologies.

Differentiator

Problem solved

Functional benefit

Products and services

  • Eyecelerator Conferences Full-day, KOL-driven business conferences held at AAO and ARVO annual meetings (e.g., Eyecelerator @ AAO 2026 on Oct. 8 in New Orleans, ARVO 2026, Eyecelerator @ Park City). Each event features presenting company showcases across three simultaneous breakout rooms, expert panels on industry advancements and investment trends, and networking sessions. Designed for ophthalmology entrepreneurs, investors, physicians, and industry leaders.
  • Eye to Market Web Series A web video series developed with Unither Pharmaceuticals and Ora that explores how ophthalmic innovations move from concept to patient care, featuring expert interviews on translational research, clinical development, manufacturing, regulatory strategy, and market access. Episodes are published on the Eyecelerator YouTube channel and shared across partner channels, targeting innovators, clinicians, investors, manufacturers, and industry leaders globally.

Quantifiable outcome

  • 40 companies present at ARVO 2026 across three simultaneous breakout rooms
  • +1 more outcomes

Companies that use Eyecelerator

Customer profile

Named customers2 records

Segments4 records

Ideal customer profiles3 records

Eyecelerator technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Eyecelerator partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and flagship.

  • American Academy of OphthalmologycoreStrategic or Co-development PartnerThe American Academy of Ophthalmology is Eyecelerator's program partner. AAO is the world's largest association of eye physicians and surgeons with 32,000 members. Eyecelerator is brought to you by AAO, which protects sight and empowers lives by setting standards for ophthalmic education and advocating for patients and the public.
  • Unither PharmaceuticalsflagshipGTM or Marketing PartnerEyecelerator announced collaboration with Unither Pharmaceuticals and Ora to launch 'Eye to Market,' a new web series exploring how ophthalmic innovations move from scientific development to real-world patient adoption. The series features expert interviews covering topics including translational research, clinical development, manufacturing, regulatory strategy, and market access.
  • Ora, Inc.flagshipGTM or Marketing PartnerEyecelerator collaboration with Ora, Inc. and Unither Pharmaceuticals on 'Eye to Market' web series. Ora is a major ophthalmology contract research organization. Episodes published on Eyecelerator YouTube channel and shared across partner channels targeting innovators, clinicians, investors, manufacturers, and industry leaders.

Scale indicators4 records

Expansion highlights4 records

Eyecelerator competitors and assessment

Company assessment

Direct peers

  • Ophthalmology Innovation Summit (OIS): Predecessor and closest direct competitor to Eyecelerator — a conference series convening ophthalmology entrepreneurs, clinicians, and investors to showcase emerging companies and technologies.
  • Biotech Showcase: Investor and partnering conference held alongside the J.P. Morgan Healthcare Conference where emerging biotech and medtech companies present to investors — same presenting-company + sponsor + investor model as Eyecelerator.
  • RESI Conference (Redefining Early Stage Investments): Life-sciences early-stage investor conference series featuring presenting companies and panel-driven programming for entrepreneurs and investors — directly comparable event format and target audience.

Broad incumbents

  • BIO International Convention: Largest global biotech partnering event operated by the Biotechnology Innovation Organization; competes for the same enterprise sponsors and presenting-company dollars across all therapeutic areas including ophthalmology.
  • J.P. Morgan Healthcare Conference: The flagship annual healthcare investment conference that draws presenting biotechs, medtechs, and investors — a major competitor for sponsor mindshare and presenting-company visibility in healthcare.
  • AAO Annual Meeting (American Academy of Ophthalmology): The parent organization's own flagship clinical meeting — provides the distribution and audience pipeline that Eyecelerator leverages, and is the platform's largest adjacent clinical event.
  • ARVO Annual Meeting (Association for Research in Vision and Ophthalmology): Premier vision-research conference where Eyecelerator co-locates its innovation programming — competing adjacent event with overlapping scientific and KOL audiences.
  • ASCRS Annual Meeting (American Society of Cataract and Refractive Surgery): Major ophthalmic surgeon society meeting with its own industry programming, exhibits, and innovation sessions that compete for sponsor and presenter attention in the ophthalmology space.

Emerging players

  • MedCity INVEST: Healthcare investor conference series with themed tracks (including medical devices) and presenting-company showcases — comparable emerging format targeting a similar investor/entrepreneur audience.

Regional players

  • BIO-Europe: Europe's largest biotech partnering conference — comparable presenting-company and sponsor model but focused on European life sciences, complementing Eyecelerator's US-centric footprint.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Eyecelerator social profiles

Digital presence

Eyecelerator financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Eyecelerator leadership team

Management profile

Number of profiles

Profiles2 records

Eyecelerator funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Eyecelerator M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Eyecelerator

What does Eyecelerator do?

Eyecelerator organizes and hosts next-generation business conferences at major ophthalmology industry meetings, including AAO (American Academy of Ophthalmology) and ARVO (Association for Research in Vision and Ophthalmology), featuring KOL-driven programs, presenting company showcases, and curated networking. It complements live events with the "Eye to Market" web series that explores ophthalmic innovation from research to patient adoption. The platform connects ophthalmology entrepreneurs, investors, physicians, and industry leaders through sponsorship, presenting company slots, and attendee registration.

Is Eyecelerator a public or private company?

Eyecelerator is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Eyecelerator founded?

Eyecelerator was founded in -1. It employs 1 to 10 people.

Where is Eyecelerator based?

Eyecelerator is headquartered in San Francisco, United States, in the North America region.

How does Eyecelerator make money?

Four revenue lines are on record. Sponsorship Revenue is the primary driver. The others are presenting Company Fees, conference Registration Fees and eye to Market Web Series.

Who are Eyecelerator's main competitors?

Direct peers on record are Ophthalmology Innovation Summit (OIS), Biotech Showcase and RESI Conference (Redefining Early Stage Investments). Broad incumbents are BIO International Convention, J.P. Morgan Healthcare Conference, AAO Annual Meeting (American Academy of Ophthalmology), ARVO Annual Meeting (Association for Research in Vision and Ophthalmology) and ASCRS Annual Meeting (American Society of Cataract and Refractive Surgery). MedCity INVEST is listed as an emerging player. BIO-Europe is listed as a regional player.

Does Eyecelerator have an API?

No public API is recorded for Eyecelerator.

What industry is Eyecelerator in?

Eyecelerator's product category is Ophthalmology Innovation Conferences. Its primary akta.pro industry code is MPAGAGAB, Professional & Association Conferences, with a secondary code of MPAGAGAM, Conferences & Conventions Operations Services (Registration, AV, Logistics). Its NAICS code is 561920 and its SIC code is 8600.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
FinancialContent Business PageOculis to Highlight Licaminlimab at Eyecelerator @ AAO 2026 and Partner with Neuro-Ophthalmology Subspecialty DayOculis CEO Riad Sherif will present Licaminlimab at Eyecelerator @ AAO 2026 on October 8, and the company will sponsor the Neuro-Ophthalmology Subspecialty Day on October 9. The PREDICT-1 registrational trial for Licaminlimab is on track for topline readout around year-end.Business Wire BlogOra Unveils Breakthrough Research in Ophthalmic Clinical Trials, New Blind Canvas Project Stories at ARVO 2026Ora announced its ARVO 2026 poster presentations on AI-driven image analysis, retinal endpoints, and dry eye treatment efficacy. The company also sponsors Eyecelerator and launches Eye to Market, while updating The Blind Canvas Project with seven storytellers' interviews.PharmafileNew web series explores path from ophthalmic research to patient accessA new YouTube web series, Eye to Market, launched by Eyecelerator with Unither Pharmaceuticals and Ora, Inc, examines how ophthalmic innovations progress from research to patient access. The series covers clinical development, regulatory strategy, manufacturing scale-up, and global access, aiming to make the process more transparent. Episodes will be published on the Eyecelerator YouTube channel.GlobeNewswireAAVantgarde to Participate in ARVO 2026, with Presentations at Key Pre-events and New Clinical Data from the LUCE Phase 1/2 StudyAAVantgarde will present interim safety and efficacy data from the LUCE-1 Phase 1/2 trial at ARVO 2026 in Denver, with pre-event talks at Eyecelerator and RTIS. The trial involves 15 patients with Usher syndrome type 1B, and the company's dual-vector AAVB-081 gene therapy targets the MYO7A gene.NewswiseEyecelerator Teams up With Unither Pharmaceuticals and Ora for Web Series on Transforming Ophthalmic Innovation into Market-Ready TherapiesEyecelerator announced a collaboration with Unither Pharmaceuticals and Ora, Inc. to launch 'Eye to Market,' a new web series exploring how ophthalmic innovations move from scientific development to real-world patient adoption. The series will feature expert interviews covering topics including translational research, clinical development, manufacturing, regulatory strategy, and market access across the ophthalmology industry. Episodes will be published on the Eyecelerator YouTube channel and shared across partner channels, targeting innovators, clinicians, investors, manufacturers, and industry leaders.GlobeNewswireNextech to Discuss Responsible AI in Healthcare at EyeceleratorNextech's Chief Medical Officer Dr. Jason Handza will present on responsible AI use in healthcare at Eyecelerator in Chicago on Oct. 17. Handza, a practicing ophthalmologist, said responsible AI can improve clinical operations and patient outcomes. Nextech also exhibits at the AAO 2024 conference.YahooNextech to Discuss Responsible AI in Healthcare at EyeceleratorNextech's Chief Medical Officer Dr. Jason Handza will present on responsible AI use in healthcare at Eyecelerator, a conference on eyecare innovations. The presentation is scheduled for Oct. 17 in Chicago, and Nextech will also exhibit at the AAO 2024 conference from Oct. 18-21.GlobeNewswireOpthea to Present at Eyecelerator Forum at the 2023 American Academy of Ophthalmology (AAO) ConferenceOpthea's founder Dr. Megan Baldwin will present at Eyecelerator at the AAO 2023 conference in San Francisco on November 2nd. The presentation highlights next-generation retinal therapeutics, with Opthea's lead candidate OPT-302 in Phase 3 trials for wet AMD and diabetic macular edema.PR NewswireNanoscope Therapeutics Wins 'Top Retina Company' Award at 2021 Eyecelerator Conference for Its Optogenetics Gene Therapy to Restore Vision in People Blinded by Retinal DiseasesNanoscope Therapeutics Inc. was awarded "Top Retina Company" at the 2021 Eyecelerator Conference held during the American Academy of Ophthalmology meeting in New Orleans for its Multi-Characteristic Opsin (MCO) optogenetic gene therapy platform designed to restore vision in patients blinded by retinal degenerative diseases such as retinitis pigmentosa. The company's lead asset MCO-010 is currently in Phase 2b multicenter, randomized, double-masked clinical trials in the U.S. after Phase 1/2a results showed patients regained vision sufficient to independently perform daily activities. Nanoscope's MCO gene therapy has received orphan drug designations from the FDA for both retinitis pigmentosa and Stargardt disease.GlobeNewswireEyenovia to Participate in Myopia Panel Discussion at the Eyecelerator@AAO 2021 MeetingEyenovia's CEO Dr. Sean Ianchulev will speak on myopia at the Eyecelerator@AAO 2021 panel on November 11 in New Orleans. The company is developing microdose array print therapeutics for myopia progression, presbyopia, and mydriasis.